Buy Doxorubicin Hydrochloride Liposome 2 mg/mL Doxorubicin Hydrochloride Liposome

Doxorubicin Hydrochloride Liposome 2 mg/mL is a liposomal formulation used for targeted chemotherapy. This intravenous suspension is designed to deliver the active ingredient directly to cancer cells, minimizing side effects. Ideal for healthcare professionals managing certain cancers.

Strength

2 mg/mL

Pack Size

1 VIAL, SINGLE-USE in 1 CARTON (0338-0080-01) / 10 mL in 1 VIAL, SINGLE-USE

Manufacturer / TM Owner

Baxter Healthcare Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Doxorubicin Hydrochloride Liposome is primarily used in the treatment of various cancers, including ovarian cancer, multiple myeloma, and Kaposi's sarcoma. This liposomal formulation is designed to target cancer cells more effectively, potentially reducing side effects compared to conventional doxorubicin. It is administered intravenously and is often part of a broader cancer treatment plan.

Side Effects

Common effects of Doxorubicin Hydrochloride Liposome may include fatigue, nausea, and hair loss. Some patients may experience more severe side effects such as heart problems or infections. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Doxorubicin Hydrochloride Liposome should be handled with care, as it is a potent chemotherapy agent. It is important to follow proper administration protocols to minimize the risk of side effects. Patients should be monitored regularly for any adverse reactions.

Avoid Interactions

Doxorubicin Hydrochloride Liposome may interact with other medications, including certain antibiotics, heart medications, and other chemotherapy drugs. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

References

Frequently Asked Questions

Doxorubicin Hydrochloride Liposome is used in the treatment of various cancers, including ovarian cancer, multiple myeloma, and Kaposi's sarcoma.

This medication is administered intravenously by a healthcare professional.

Common side effects may include fatigue, nausea, and hair loss. Severe side effects can include heart problems or infections.

It may interact with other medications, so always inform your healthcare provider about all medications you are taking.

It should be handled with care and administered by a healthcare professional to minimize the risk of side effects.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.